Serotonin Antagonism Improves Platelet Inhibition in Clopidogrel Low-Responders after Coronary Stent Placement: An In Vitro Pilot Study

Increased residual platelet reactivity remains a burden for coronary artery disease (CAD) patients who received a coronary stent and do not respond sufficiently to treatment with acetylsalicylic acid and clopidogrel. We hypothesized that serotonin antagonism reduces high on-treatment platelet reacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Duerschmied, Daniel, Ahrens, Ingo, Mauler, Maximilian, Brandt, Christoph, Weidner, Stefanie, Bode, Christoph, Moser, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287984/
https://www.ncbi.nlm.nih.gov/pubmed/22384279
http://dx.doi.org/10.1371/journal.pone.0032656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287984/
https://www.ncbi.nlm.nih.gov/pubmed/22384279
http://dx.doi.org/10.1371/journal.pone.0032656

Ejemplares similares